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Abstract
Urticaria is a common mast cell‐driven disease which is characterized by red, itchy swell‐
ings. Urticaria, that persists more than 6 weeks in a repetitive manner (each lesion disap‐
pearing in <24 h), is called chronic urticaria. Chronic urticaria can be either spontaneous 
without the need of a trigger, or inducible in which with a known trigger the lesions can 
be provoked. Chronic inducible urticarias include the physical urticarias and some other 
forms such as cholinergic urticaria.
Keywords: urticaria, chronic urticaria, inducible urticaria, cholinergic urticaria, contact 
urticaria
1. Introduction
Urticaria, also known as hives, is a common, mast cell‐driven, itchy condition which is char‐
acterized by red/pink, swollen whealing of the skin [1]. The lesions can vary from a few mil‐
limeters to tens of centimeters. Chronic urticaria is defined when the transient lesions that 
disappear in <24 h and last more than 6 weeks in repetitive manner [2]. Most of the chronic 
urticaria cases are idiopathic [3]. Chronic spontaneous urticaria is the spontaneous appear‐
ance of wheals, angioedema or both due to known or unknown causes for a period longer 
than 6 weeks. In case of a known trigger that causes whealing, angioedema or both at every 
exposure, chronic inducible urticaria term is used. Chronic inducible urticarias consist of 
physical urticarias (PUs) and cholinergic urticaria (CU) [1, 3, 4]. Figure 1 demonstrates the 
classification of urticaria according to EAACI/GA2LEN/WAO 2013 guideline.
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Physical urticaria (PU) is a subgroup of acquired, chronic inducible urticaria which is associ‐
ated with a known physical trigger [5]. In PU, the symptoms are induced by exogenous physi‐
cal triggers such as friction, pressure, vibration, cold, heat or solar radiation. All the PUs may 
manifest with both wheals and angioedema at the sites of the triggers with the exceptions 
that urticaria factitia (symptomatic dermographism) presents with wheals only and pressure 
urticaria presents with angioedema only [6, 7]. Table 1 summarizes the types and subtypes of 
chronic inducible urticaria and the triggering agents.
Cholinergic urticaria is another subtype of inducible urticaria. Because of the fact that the 
symptoms are not triggered by exogenous physical exposure, cholinergic urticaria is not con‐
sidered as PU. Rather, it is induced by an increase in the body core temperature [8].
Almost 0.5% of the population suffers from chronic inducible urticaria that makes nearly 
15–25% of all chronic urticarias [7]. All forms of urticaria do not only cause impaired quality of 
Type Subtypes Trigger
Physical urticarias Cold urticaria Cold contact (air, water and solid)
Delayed pressure urticaria Vertical pressure
Heat urticaria Hot contact (air, water and solid)
Solar urticaria UV or visible light
Symptomatic dermographism Mechanical stroking
Vibratory urticaria Vibration
Other inducible urticarias Aquagenic urticaria Water at any temperature
Contact urticaria (Non)immunological contactant
Cholinergic urticaria Increment of body temperature
Exercise‐induced anaphylaxis Physical exercise
Table 1. Classification of chronic inducible urticaria.
Figure 1. Classification of urticaria, according to EAACI/GA2LEN/WAO 2013 guideline.
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life but also affect performance at social life, school and work [9]. PU is classified  depending on 
the type of the physical trigger. They are diagnosed by using different provocation tests induc‐
ing wheals and sometimes angioedema [3]. It is important to make provocation tests after tak‐
ing the patient’s history in order to get a proper diagnosis. One must be very careful during the 
provocation tests as systemic symptoms including shock can develop along the course [10]. In 
chronic inducible urticaria, the threshold of the causative trigger must be established to assess 
the severity of the condition. These threshold levels also allow us to evaluate the activity of the 
diseases and the response to the therapy [11]. PU generally accompanies other forms of chronic 
urticaria such as spontaneous urticaria and/or other inducible urticaria types. Therefore, every 
patient with one of the PUs must be tested with all physical triggers that seem to be relevant 
from the medical history [12]. The result of the provocation test changes according to the medi‐
cal status of the patient. That’s why the test should be done prior to the treatment if possible. 
Testing should be performed on skin areas which have not been complicated with wheals 
recently. Because affected skin areas exhibit a refractory period after urticarial reactions. In 
case of a negative result despite a strong suspicion, the testing can be repeated several times. In 
cholinergic urticaria, the patient must be asymptomatic for 48 h before testing [6].
2. Cholinergic urticaria (CU)
Cholinergic urticaria, simply, is a type of chronic urticaria which is triggered by elevated 
body temperature. Physical exercise, strong emotions, hot or spicy food and hot showers 
seem to be the most common causes [13]. CU accounts for 5% of all chronic urticaria cases [7]. 
Generalized flushing, itching and wheals surrounded by macular erythema make the clini‐
cal picture in CU. The lesions spread from the trunk and neck to the extremities. Some of the 
CU cases are complicated with systemic symptoms such as hypotension, angioedema and 
bronchospasm [14]. CU due to exercise starts 5–10 min after the beginning of the exercise and 
maximizes after 12–25 min [15].
The pathophysiology in CU is thought to be related to the elevation of histamine in the serum. 
Adachi et al. proposed that CU occurs after a type 1 allergic reaction to the patient’s own 
sweat. They reported that the patients underwent autologous sweat testing and demonstrated 
an immediate skin reaction [8].
In case of a suspicion, confirmatory testing should be conducted. Appearance of whealing 
after the intradermal injection of 0.01 mg methacholine in 0.1 ml saline is diagnostic. Assuming 
that only one‐third of the patients demonstrate positive testing CU cannot be ruled out with a 
negative provocation test [9]. Specific provocative challenges such as exercise, hot showers or 
spicy food trials can also be tried. The best way to provoke is to increase the individual’s body 
temperature by submerging the patient in a hot water bath at 40°C. Developing of general‐
ized hives confirms the diagnosis [6]. Unfortunately, this testing can have interference with 
aquagenic urticaria (AU) or heat urticaria.
Best treatment of CU is the avoidance of the offending stimulus in cases where possible. First‐
line medical therapy is the oral antihistamines. Hydroxyzine is believed to be more effec‐
tive than the others [16]. Oral anticholinergics have been tried with failure mostly. Use of 
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pre‐ exercise propranolol 80 mg daily has been found effective in controlling the symptoms 
of CU [17]. These data have not been supported by further studies because of the fact that 
beta‐blockers, themselves, cause allergic reactions.
The prognosis of CU is mostly pleasing. About 70% of the patients heal within 10 years of 
the diagnosis. Sibbald et al. estimated the duration of CU to be 3–16 years with an average of 
7.5 years [2].
Cholinergic urticaria must be distinguished from exercise‐induced anaphylaxis (EIA). The 
main symptoms of EIA include laryngospasm, bronchospasm, vascular collapse, fatique, 
vocal changes, gastrointestinal upset, flushing and hives [18]. In contrast to CU, the urticarial 
plaques are larger, up to 10–15 mm. All types of exercise including walking can be the trigger. 
In EIA, although the anaphylaxis symptoms are at the forefront, only a few cases of death 
have been reported [19].
EIA is treated like any other forms of anaphylaxis. Epinephrine is the life‐saving treatment. 
Diphenhydramine 25–50 mg is helpful. Systemic steroids are used to prevent delayed bipha‐
sic reactions [20]. Any individual with the diagnosis of EIA should carry an epinephrine auto‐
injector [21]. Cetirizine and montelukast combination also has been reported to be useful in 
preventing symptoms of EIA [22].
CU can be differentiated from EIA with the size of the whealings. Also, in CU, the hives are in 
the front, whereas the edema and the anaphylaxis are in the front in case of EIA. In addition, 
passive warming test in a bath and methacholine injection tests are positive in CU [23].
3. Aquagenic urticaria (AU)
Aquagenic urticaria (AU) is a rare form PU which is characterized by wheals following cuta‐
neous exposure to water, including tears and sweat. Mostly, 1–3 mm follicular wheals and 
1–3 cm erythematous flares surrounding them are present. The lesions develop 20–30 min 
after exposure to water. Lesions usually resolve in 30–60 min after the cessation of contact 
to water [4]. Most of the patients are peri‐pubertal females. Trunk and proximal arms are 
the most commonly affected sites, sparing palms and soles [5]. Wheezing and dyspnea can 
accompany the lesions. When there is such a systemic symptom, large lesions rather than 
1–3 mm punctate lesions are present [24].
Most of the AU cases are sporadic. However, there are some reports of familial cases. No spe‐
cific gene locus has been identified so far [5]. There are few cases showing the association of 
AU and HIV infection and papillary thyroid gland carcinoma [25, 26].
The pathogenesis of AU is not clear yet. In 1981, Tkach hypothesized that sudden changes in 
osmotic pressure around hair follicles, leading to passive diffusion of water caused whealing 
[27]. A recent proposal involves existence of water‐soluble antigens in the epidermis which 
later migrate to dermis and cause histamine release [10]. The lack of a proper etiologic mecha‐
nism makes AU difficult to treat.
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Water challenge test is necessary for the proper diagnosis. For this, water at room temperature 
is applied to a cloth, and this cloth is applied to patient’s skin for 20 min. In case of an urticar‐
ial lesion, the provocation test is considered as positive. Water should be at room temperature. 
Because, if the temperature is higher or lower, the test could give arise to other forms of PU 
(cold or heat urticaria) [28]. Bayle et al. reported a case with AU, dermatographism and cho‐
linergic urticaria at the same time [29]. It is possible to induce AU, heat urticaria, cold urticaria 
and cholinergic urticaria with applying water at different temperatures [30]. So, one should be 
very careful to differentiate among these conditions.
Management of AU is difficult. Avoidance is almost impossible. The first‐line therapy is H1 
antihistamines [11]. Long acting newer antihistamines with fewer side effects are usually pre‐
ferred. H2 receptors are thought to be not operating in the pathogenesis of PU. Yet there is a 
case report that claims that H2 antihistamines reduce wheal response [31].
Topical barrier therapies show promising results in AU. They are also safer. Application of 
oil‐in‐water emulsions before bathing can reduce wheals. Such physical barriers must be used 
in the pediatric patients before everything else to prevent the potential side effects of the anti‐
histamines [29].
Phototherapy, both PUVA and narrow‐band UVB, has been reported to be effective in AU 
treatment. Possible action of mechanism is the reduction of mast cell activity and thickening 
of the skin, mostly epidermis, leading to decreased water penetration [32].
Stanozolol which is used in the treatment of hereditary angioedema was shown to be effective 
in one male patient at a dose of 10 mg daily [25].
4. Contact urticaria
Contact urticaria is the transient whealing and flare of the skin after contact with certain 
agents. The lesions appear within 60 min of contact and mostly resolve in 2–24 h [33]. Contact 
urticaria can be both immunological (IgE mediated) or non‐immunological. Mostly, non‐
immunological mechanisms are seen. It can be provoked in all persons without the need of 
prior sensitization [34].
The lesions in contact urticaria appear as a result of the release of vasoactive amines such as 
histamine, leukotrienes, substance P and prostaglandins, independent from immunological 
processes. The lesions are localized to the contact area causing no systemic symptoms. The 
causative contact agents can be insects, metals, alcohol, balsam of Peru, sodium benzoate, 
sorbic acid, fruits, vegetables, jellyfish, sea anemones and corals [33–35].
Contact urticaria is rarely due to immunological causes, that is, allergic. In this case, it is caused 
by antigen‐antibody type 1 IgE‐mediated hypersensitivity reaction. The contact antigen pen‐
etrates the skin and binds with specific IgE antibodies on dermal mast cells. Histamine and 
some other mediators such as kinin and prostaglandins are released. As a result, erythema 
and hives are observed [35]. Sometimes systemic symptoms (rhinitis, conjunctivitis and 
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asthma) can accompany the cutaneous manifestations [36]. The triggering agent in contact 
urticaria can be rubber latex, antibiotics (cephalosporins and streptomycin), foods (potato, 
fish and apple), cosmetics (hair bleaching products and paraphenylenediamine) and chemi‐
cals (isocyanates, chlorhexidine and aluminum) [35].
The mainstay of the therapy is mainly avoidance in contact urticaria [7]. Barrier creams are 
being used recently with good results [37]. H1 antihistamines make the first line therapy. 
In case of failure, dose increment, leukotriene antagonists, cyclosporine, omalizumab can be 
used with variable success rates [34, 35, 37].
5. Conclusion
As a result, we should keep in mind that chronic urticaria is hard to manage. The treatment 
should be individualized most of the time because of the fact that one patient can respond 
well to a specific treatment but another patient cannot. Another fact, to remember, is to dif‐
ferentiate cholinergic urticaria from exercise‐induced anaphylaxis. Because they are similar 
entities, but they have different therapy options and courses.
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